This CE activity was originally published in The Rx Consultant. If you received credit for it previously, you cannot receive credit for it again.
Asthma is a chronic inflammatory disease that affects over 339 million individuals worldwide. Characterized by variable airflow limitation and bronchial hyperresponsiveness, symptoms include wheezing, shortness of breath, chest tightness, and/or cough. Asthma symptoms are episodic in nature, often worse at night or in the early morning, and can be triggered by factors such as exercise, airborne allergens, pollution, cigarette smoking, weather changes (eg, very cold, low humidity), and viral upper respiratory infections. To diagnose asthma, patients must have a history of variable respiratory symptoms, as well as limited expiratory airflow that has been confirmed with spirometry.
The long-term goals of asthma management are to achieve good symptom control that enables patients to maintain normal activity levels, to minimize persistent airflow limitation, side effects from treatment, and asthma-related exacerbations, and to prevent asthma-related death...
Fee
CE Hours
CE Units
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses
- Pharmacists
- Nurse Practitioners
Accreditation(s)
CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours. CE credit is automatically reported to CPE Monitor.
The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
- The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
- Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.
- Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.
Requirements for CE Credit
Objectives
- Discuss the current GINA recommendations for stepwise treatment of asthma, including the role for SABA, LABA, and inhaled corticosteroids (ICS). Recognize ICS-LABA combination products approved for the treatment of asthma and their age-specific daily doses.
- Discuss the reasons and possible solutions for poor asthma medication adherence. Provide 2 examples of personalized controller therapy that may not be consistent with general treatment recommendations in clinical practice guidelines.
- Describe the rationale for the use of biologics in patients with severe asthma uncontrolled by ICS and bronchodilator therapy. List approved agents, dosing, and potentially serious side effects.
Speaker(s)/Author(s)
|
Jessica Wallace, PharmD
Brief Bio : Jessica Wallace, PharmD, BCPS is an Assistant Professor of Pharmacy Practice at Lipscomb University College of Pharmacy and Health Sciences in Nashville, TN. She maintains a practice site precepting students and residents on the Internal Medicine Service at the Veterans Affairs Tennessee Valley Healthcare System, Nashville. |
|
|
Jonathan Hughes, PharmD, BCPS, BCACP
Brief Bio : Jonathan Hughes, PharmD, BCPS, BCACP is an Ambulatory Care Clinical Pharmacist Specialist at the Saint Louise Family Medicine Center in Murfreesboro, TN. He is also an Assistant Professor for the University of Tennessee Health Science Center, holding joint appointments with the Department of Clinical Pharmacy, College of Pharmacy, and the Department of Clinical Medical Education, College of Medicine. |
Activity Number
0428-0000-20-002-H01-P